VWM
GILD icon

Vermillion Wealth Management’s Gilead Sciences GILD Stock Holding History

Vermillion Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Sell
100
-691
-87% -$91K ﹤0.01% 1041
2026
Q1 		$110K Buy
791
+68
+9% +$9.52K 0.04% 139
2025
Q4 		$88.8K Buy
723
+623
+623% +$75.7K 0.04% 147
2025
Q3 		$11.1K Hold
100
– – ﹤0.01% 1024
2025
Q2 		$11.1K Sell
100
-611
-86% -$65K 0.01% 328
2025
Q1 		$79.6K Buy
711
+5
+0.7% +$516 0.02% 434
2024
Q4 		$65.2K Buy
+706
New +$63.6K 0.03% 159

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vermillion Wealth Management's GILD Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Gilead Sciences (GILD) stake by 87% in Q2 2026, selling an estimated $91K and leaving 100 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Vermillion Wealth Management first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $110K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Vermillion Wealth Management held 100 shares of Gilead Sciences worth $12.6K as of Q2 2026.
  • Vermillion Wealth Management sold 691 Gilead Sciences shares in Q2 2026, an estimated $91K.
  • Gilead Sciences made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1041 holding.
  • Vermillion Wealth Management first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Gilead Sciences position peaked at $110K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.